A prospective study of interactions between a case management program and retention in care on HIV suppression in Taiwan, 2008-2012.

Dear Editor Achieving optimal antiretroviral treatment outcomes is a fundamental treatment as prevention (TasP) strategy. A successful program for HIV treatment includes making the diagnosis of HIV infection, linking infected individuals to outpatient care, and retaining patients in care. Case management (CM) has been shown to facilitate entry and engagement in care among persons living with HIV. In the United States, HIV CM is a federally legislated program funded by the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act of 1990 (now the Ryan White Treatment Modernization Act). Japan, Brazil, and Rwanda have also initiated a integrated case management program by the government. HIV-infected patients in Taiwan have been provided with free antiretroviral therapy and medical care at AIDS-designated hospitals since the early 1990s. An estimated 70% of individuals living with HIV infection in Taiwan have sought HIV care, and 40% of individuals who have sought HIV care received HAART after the diagnosis of HIV infection with CD4 cell counts < 350 cells/mm. In 2005, the Taiwan Center for Disease Control (Taiwan CDC) initiated an HIV case management (CM) program in AIDS-designated hospitals to provide integrative services and risk reduction counseling for HIV-infected individuals. The current study provides a unique opportunity to observe the impact of HIV case management on achieving the optimal therapeutic effect of HAART among HIV-infected persons. A longitudinal prospective cohort study was conducted at an AIDS-designated hospital, National Cheng Kung University Hospital (NCKUH), with over 15 years of experience caring for HIV-infected patients in southern Taiwan. A total of 549 patients who were newly diagnosed during 2008–2012 provided data for analysis. Of the 549 patients, 427 (77.8%) ever enrolled in the hospital-based HIV case management program. Retention in care was defined as having two or more HIV clinical visits separated by ‡ 90 days during a calendar year over the 5-year observation period. Achievement of viral suppression was defined as the first HIV RNA level of < 400 copies per milliliter, and time to viral suppression was defined as the number of days between the initial diagnosis of HIV and the first viral load (VL) of < 400 copies per milliliter. Patients who never had a VL > 1000 copies per milliliter after viral suppression (VL < 400 copies per milliliter) by the time of death or at the end of the analysis period were considered to have maintained suppression. Of the 549 patients, the mean age was 31.6 years (SD 9.7, range: 16–77 years), 95.3% were male, and 69.2% reported men having sex with men (MSM) as a primary risk factor for HIV transmission. Median initial CD4 count during the year rose from 55.2 to 185.9 cells/mm. Applying the pre-2013 HAART initiation threshold of CD4 < 350 cells per cubic millimeter, 52–60% would have been eligible to begin HAART based on the first CD4 after the initial diagnosis. Almost two-thirds (n = 335, 72.2%) of the patients were retained in care until the end of the 5-year study period. The adjusted multivariate logistic regression indicated that persons retained in HIV care were significantly more likely to be female [adjusted odds ratio (aOR) 0.25, 95% confidence interval (CI): 0.75–0.84], to have initiated HAART (aOR 4.91, 95% CI: 2.81–8.60), and to be enrolled in the case management program (aOR 2.15, 95% CI: 1.11–4.16) than persons not retained in care during years 2008–2012. Overall, 257 (61.8%) of the patients newly diagnosed with HIV during 2008–2012 ever achieved viral suppression by the end of 2012; 26.6% achieved suppression within 6 months of diagnosis, and 39.8% within 12 months. Overall, 57.6% of the 257 persons who ever achieved viral suppression maintained their suppression for 12 months. Cox proportional hazards models showed significant interaction effects between retention in care and enrollment in CMP on viral suppression (Table 1). The patients were divided into three groups: retained in care plus case management (n = 294, 53.6%), either retained in care or enrolled in case management only (n = 174, 31.4%), and irregular/lost to follow-up and also without case management (n = 81, 14.8%). The Kaplan-Meier survival analysis showed that patients who were retained in care and also enrolled in CMP had the best outcomes of achieving viral